Evidence map›Paper›PMID 32328638›Full record

ArticleThe Journal of cell biology2020

FXR1 splicing is important for muscle development and biomolecular condensates in muscle cells.

Jean A Smith, Ennessa G Curry, R Eric Blue, Christine Roden, Samantha E R Dundon, Anthony Rodríguez-Vargas, Danielle C Jordan, Xiaomin Chen, Shawn M Lyons, John Crutchley and 4 more

Open access · greenAbstract read
In one paragraph

Article in The Journal of cell biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. The FXR1 network acts as signaling scaffold for actomyosin remodeling.bioRxiv : the preprint server for biology · 2024
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. RNA mNature genetics · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Jean A SmithDepartment of Biology, Stetson University, DeLand, FL.
Ennessa G CurryDepartment of Cell Biology & Physiology, University of North Carolina at Chapel Hill, Chapel Hill, NC.
R Eric BlueDepartment of Cell Biology & Physiology, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Christine RodenDepartment of Biology, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Samantha E R DundonDepartment of Molecular, Cellular, and Developmental Biology, Yale University, New Haven, CT.
Anthony Rodríguez-VargasEugene Bell Center for Regenerative Biology and Tissue Engineering and National Xenopus Resource, Marine Biology Laboratory, Woods Hole, MA.
Danielle C JordanEugene Bell Center for Regenerative Biology and Tissue Engineering and National Xenopus Resource, Marine Biology Laboratory, Woods Hole, MA.
Xiaomin ChenDepartment of Cell Biology & Physiology, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Shawn M LyonsDivision of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA.
John CrutchleyDepartment of Biology, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Paul AndersonDivision of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA.
Marko E HorbEugene Bell Center for Regenerative Biology and Tissue Engineering and National Xenopus Resource, Marine Biology Laboratory, Woods Hole, MA.
Amy S GladfelterDepartment of Biology, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Jimena GiudiceDepartment of Cell Biology & Physiology, University of North Carolina at Chapel Hill, Chapel Hill, NC.
University of North Carolina at Chapel Hill · USMarine Biological Laboratory · USBrigham and Women's Hospital · USYale University · US

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI David Darr · 1985 to 2026
$201.5M
Re-Entry Supplement: Investigation of Oral Microbial Enzymes for the Detection and Treatment of Periodontal DiseaseUL1TR002489 · NCATS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BUSE, JOHN BERNARD, SHAHEEN, NICHOLAS J · 2018 to 2022
$48.6M
UNIV OF NORTH CAROLINA CLINICAL NUTRITION RESEARCH UNITP30DK056350 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Ian Michael Carroll · 1999 to 2026
$31.6M
Integrated Training in Cancer Model SystemsT32CA009156 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DER, CHANNING J. · 1985 to 2020
$19.7M
Resource CoreP40OD010997 · OD · MARINE BIOLOGICAL LABORATORY · PI Marko E Horb · 2012 to 2026
$13.1M
UNC Initiative for Maximizing Student DevelopmentR25GM055336 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI COOK, JEANETTE GOWEN, KASH, THOMAS L. · 1996 to 2023
$12.1M
UNC PREP in the Biomedical Sciences - Administrative SupplementR25GM089569 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ROBINSON, DONITA L, RODRIGUEZ-ROMAGUERA, JOSE · 2010 to 2024
$5.6M
Cytoplasmic Organization by phase transitionsR01GM081506 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI GLADFELTER, AMY S · 2010 to 2023
$4.0M
Xenopus models of human disease by targeted genome editingR01HD084409 · NICHD · MARINE BIOLOGICAL LABORATORY · PI HORB, MARKO E · 2015 to 2019
$2.9M
Cellular Stress Response MechanismsR35GM126901 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI ANDERSON, PAUL J. · 2018 to 2022
$2.9M
Equipment -NEON transfection equipmentR01GM130866 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI GIUDICE, JIMENA · 2019 to 2023
$1.6M
Regulation of Ribosome Biogenesis During StressR00GM124458 · NIGMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI LYONS, SHAWN M · 2020 to 2022
$734k
Howard Hughes Medical InstituteNCATS NIH HHS UL1 TR002489NCI NIH HHS P30 CA016086NCI NIH HHS T32 CA009156NICHD NIH HHS R01 HD084409NIDDK NIH HHS P30 DK056350NIGMS NIH HHS F32 GM136164NIGMS NIH HHS K99 GM124458NIGMS NIH HHS R00 GM124458NIGMS NIH HHS R01 GM081506NIGMS NIH HHS R01 GM130866NIGMS NIH HHS R25 GM055336NIGMS NIH HHS R25 GM089569NIGMS NIH HHS R35 GM126901NIH HHS P40 OD010997
6 · The paper itself

Abstract

Fragile-X mental retardation autosomal homologue-1 (FXR1) is a muscle-enriched RNA-binding protein. FXR1 depletion is perinatally lethal in mice, Xenopus, and zebrafish; however, the mechanisms driving these phenotypes remain unclear. The FXR1 gene undergoes alternative splicing, producing multiple protein isoforms and mis-splicing has been implicated in disease. Furthermore, mutations that cause frameshifts in muscle-specific isoforms result in congenital multi-minicore myopathy. We observed that FXR1 alternative splicing is pronounced in the serine- and arginine-rich intrinsically disordered domain; these domains are known to promote biomolecular condensation. Here, we show that tissue-specific splicing of fxr1 is required for Xenopus development and alters the disordered domain of FXR1. FXR1 isoforms vary in the formation of RNA-dependent biomolecular condensates in cells and in vitro. This work shows that regulation of tissue-specific splicing can influence FXR1 condensates in muscle development and how mis-splicing promotes disease.

Indexed as

AdultAgedAlternative SplicingAnimalsCells, CulturedFemaleHumansInfantMaleMiceMice, Inbred C57BLMice, Inbred StrainsMiddle AgedMuscle CellsMuscle DevelopmentMusclesFxr1h protein, mouseFXR1 protein, humanFXR1 protein, XenopusRNA-Binding ProteinsXenopus Proteins

Identifiers

PMID32328638
PMCPMC7147106
OpenAlexW3010705122

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.